Taastrup, Denmark

Paw Bloch

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 414(Granted Patents)


Location History:

  • Taastrup, DK (2005 - 2017)
  • Jyllinge, DK (2015 - 2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations of Paw Bloch in Obesity Treatment

Introduction

Paw Bloch, an innovative inventor based in Taastrup, Denmark, has made significant contributions to the field of obesity treatment with a total of 13 patents. His work focuses on developing unique compounds that target the mechanisms involved in body weight regulation, which holds great potential for addressing the growing obesity epidemic worldwide.

Latest Patents

Among Paw Bloch's latest inventions is a construct for the treatment of obesity. This invention comprises a compound that specifically targets areas in the brain responsible for body weight regulation, paired with an allosteric ligand to a receptor at the blood-brain barrier (BBB). It aims to create compositions effective in preventing and treating overweight and obesity by utilizing GLP-1 receptor agonists (GLP-1RA) and transferrin receptors (TfR). Remarkably, the in vivo studies in mice have demonstrated that this construct results in a significant reduction in food intake and leads to substantial weight loss compared to inactive constructs.

In addition, Bloch's innovation includes double-acylated GLP-1 compounds, designed as derivatives of the GLP-1 peptide. These derivatives carry two lysine residues at specific positions and allow for the attachment of protractors via linkers, enhancing their potency and enabling potential oral administration. The pharmaceutical uses of these compounds extend beyond obesity treatment to include diabetes management.

Career Highlights

Throughout his career, Paw Bloch has held significant roles at renowned companies, particularly at Novo Nordisk A/S, where he focused on advancing research related to obesity and diabetes. This experience has strengthened his ability to innovate in this critical area of health.

Collaborations

Paw Bloch has collaborated with notable colleagues, including Jesper F. Lau and Janos Tibor Kodra. Their joint efforts have contributed to the development of effective solutions in the pharmaceutical field, underscoring the importance of teamwork in tackling complex health issues.

Conclusion

Paw Bloch's inventive research in obesity treatment demonstrates his commitment to improving public health through innovative solutions. His patents reflect a profound understanding of the scientific mechanisms involved in body weight regulation and the potential for new treatments that could substantially impact countless lives. As he continues to work and collaborate with other leading professionals, the future of obesity management looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…